Edap Tms Sa ADR (EDAP)

$3.22 -0.07 (-2.13%)
Market Cap 120.69M
Revenue (ttm) 70.53M
Net Income (ttm) -29.25M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -41.47%
Debt to Equity Ratio 1.24
Volume 6,200
Avg Vol 40,586
Day's Range N/A - N/A
Shares Out 37.48M
Stochastic %K 17%
Beta -0.09
Analysts Sell
Price Target $5.50

Company Profile

EDAP TMS S.A., together with its subsidiaries, develops, manufactures, promotes, and distributes minimally-invasive medical devices for urology based upon proprietary ultrasound technology in Asia, France, the United States, and internationally. The company operates through High Intensity Focused Ultrasound (HIFU), Extracorporeal ShockWave Lithotripsy (ESWL), and Distribution segments. The HIFU segment develops, manufactures, markets, and distributes non-invasive robotic HIFU systems for urology...

Industry: Medical Distribution
Sector: Healthcare
Phone: 33 4 72 15 31 50
Address:
Parc dActivites la Poudrette-Lamartine, 4/6, rue du DauphinE, Vaulx-En-Velin, France
Georges8792
Georges8792 Apr. 24 at 7:45 AM
$EDAP https://www.linkedin.com/posts/joshua-darley-999507115_roboticsurgery-gynaecology-endometriosis-share-7453346687919656960-dqAB?utm_source=social_share_send&utm_medium=ios_app&rcm=ACoAADRx6v4B54eq7jmLG3UwhtnBprtqfVsygQg&utm_campaign=share_via
0 · Reply
Georges8792
Georges8792 Apr. 23 at 4:51 AM
$EDAP https://www.linkedin.com/posts/prakash-singh-30b07a338_the-future-of-prostate-cancer-treatment-is-share-7452528077110272000-RDnM?utm_source=social_share_send&utm_medium=ios_app&rcm=ACoAADRx6v4B54eq7jmLG3UwhtnBprtqfVsygQg&utm_campaign=share_via
0 · Reply
finedge
finedge Apr. 21 at 6:42 PM
$EDAP watch for enhanced entry opportunity Mid May..Short term play as Tatiff -Freight on Delivey has increased and company will have to absorb.
2 · Reply
Georges8792
Georges8792 Apr. 21 at 5:15 PM
$EDAP https://www.linkedin.com/posts/cancer-prostatecancer-urology-share-7452397483571474432-7OvJ?utm_source=social_share_send&utm_medium=ios_app&rcm=ACoAADRx6v4B54eq7jmLG3UwhtnBprtqfVsygQg&utm_campaign=share_via
0 · Reply
Georges8792
Georges8792 Apr. 21 at 7:39 AM
$EDAP https://www.linkedin.com/posts/gil-dubernard-md-phd-endometriosis-expert-surgeon-and-sonologist-196bab135_hifu-endometriosis-share-7452086340013338625-q1ze?utm_source=social_share_send&utm_medium=ios_app&rcm=ACoAADRx6v4B54eq7jmLG3UwhtnBprtqfVsygQg&utm_campaign=share_via
0 · Reply
Georges8792
Georges8792 Apr. 21 at 7:38 AM
$EDAP https://www.linkedin.com/posts/vincent-bailly-995824209_focal-one-first-treatment-sweden-ugcPost-7451957981723877377-UV-q?utm_source=social_share_send&utm_medium=ios_app&rcm=ACoAADRx6v4B54eq7jmLG3UwhtnBprtqfVsygQg&utm_campaign=share_via
0 · Reply
mikegrand
mikegrand Apr. 19 at 11:47 PM
$EDAP one thing I’ve looked over that was pretty big was the collaboration with IRCAD, I’ve never really looked into them because it wasn’t a hospital system but that’s pretty big that EDAP is the primary focal therapy machine in their facility. IRCAD is regarded as the number one minimally invasive training facility in the world and they train over 5000 doctors annually. This will vastly increase the amount of doctors that know Focal One and as of right now they only have a machine in Strasbourg but I expect them to expand to the other training facilities across the globe
0 · Reply
finedge
finedge Apr. 17 at 1:38 PM
$EDAP adjusting prediction date fluid markets
2 · Reply
finedge
finedge Apr. 17 at 1:38 PM
$EDAP
0 · Reply
Georges8792
Georges8792 Apr. 17 at 1:33 PM
$EDAP https://www.linkedin.com/posts/urooncologia-cirurgiaminimamentelnvasiva-ugcPost-7450612787254525952-BSWb?utm_source=social_share_send&utm_medium=ios_app&rcm=ACoAADRx6v4B54eq7jmLG3UwhtnBprtqfVsygQg&utm_campaign=share_via
0 · Reply
Latest News on EDAP
EDAP to Announce First Quarter 2026 Financial Results on May 7, 2026

Apr 16, 2026, 7:30 AM EDT - 9 days ago

EDAP to Announce First Quarter 2026 Financial Results on May 7, 2026

EDAP Reports Record Fourth Quarter and Full-Year 2025 HIFU Revenue

Mar 25, 2026, 7:30 AM EDT - 4 weeks ago

EDAP Reports Record Fourth Quarter and Full-Year 2025 HIFU Revenue

EDAP to Present at Oppenheimer 36th Annual Healthcare MedTech & Services Conference

Mar 10, 2026, 7:30 AM EDT - 6 weeks ago

EDAP to Present at Oppenheimer 36th Annual Healthcare MedTech & Services Conference

EDAP to Announce Fourth Quarter and Full Year 2025 Financial Results on March 25, 2026

Mar 4, 2026, 7:30 AM EST - 7 weeks ago

EDAP to Announce Fourth Quarter and Full Year 2025 Financial Results on March 25, 2026

EDAP Announces Appointment of David Horn to Board of Directors

Feb 12, 2026, 7:30 AM EST - 2 months ago

EDAP Announces Appointment of David Horn to Board of Directors

EDAP Announces Preliminary Record Fourth Quarter and Full Year 2025 HIFU Revenue; Issues 2026 Revenue Guidance

Jan 12, 2026, 7:30 AM EST - 3 months ago

EDAP Announces Preliminary Record Fourth Quarter and Full Year 2025 HIFU Revenue; Issues 2026 Revenue Guidance

EDAP Receives FDA 510(k) Clearance for Latest Evolution of Focal One Robotic HIFU

Nov 20, 2025, 7:30 AM EST - 5 months ago

EDAP Receives FDA 510(k) Clearance for Latest Evolution of Focal One Robotic HIFU

EDAP to Present at Piper Sandler 37th Annual Healthcare Conference

Nov 18, 2025, 7:00 AM EST - 5 months ago

EDAP to Present at Piper Sandler 37th Annual Healthcare Conference

EDAP Reports Third Quarter 2025 Financial Results

Nov 6, 2025, 7:30 AM EST - 6 months ago

EDAP Reports Third Quarter 2025 Financial Results

EDAP to Present at Jefferies Global Healthcare Conference in London

Nov 4, 2025, 7:00 AM EST - 6 months ago

EDAP to Present at Jefferies Global Healthcare Conference in London

EDAP to Participate in the UBS Global Healthcare Conference

Oct 27, 2025, 7:00 AM EDT - 6 months ago

EDAP to Participate in the UBS Global Healthcare Conference

EDAP to Announce Third Quarter 2025 Financial Results on November 6, 2025

Oct 23, 2025, 7:00 AM EDT - 6 months ago

EDAP to Announce Third Quarter 2025 Financial Results on November 6, 2025

EDAP Secures €36 Million Credit Facility from European Investment Bank to Accelerate Growth of Focal One® Robotic HIFU

Oct 20, 2025, 8:30 AM EDT - 6 months ago

EDAP Secures €36 Million Credit Facility from European Investment Bank to Accelerate Growth of Focal One® Robotic HIFU

Focal One® Prostate Cancer Awareness Month Campaign Shines Spotlight on Robotic HIFU Treatment Option

Sep 30, 2025, 7:00 AM EDT - 7 months ago

Focal One® Prostate Cancer Awareness Month Campaign Shines Spotlight on Robotic HIFU Treatment Option

Focal One® HIFU Receives Prestigious Innovation Award

Sep 16, 2025, 7:00 AM EDT - 7 months ago

Focal One® HIFU Receives Prestigious Innovation Award

EDAP Receives HIFU Reimbursement for Prostate Cancer in France

Sep 8, 2025, 7:00 AM EDT - 8 months ago

EDAP Receives HIFU Reimbursement for Prostate Cancer in France

EDAP Reports Strong Second Quarter 2025 HIFU Results

Aug 28, 2025, 7:00 AM EDT - 8 months ago

EDAP Reports Strong Second Quarter 2025 HIFU Results

EDAP Announces Letter of Intent for 36 Million Euro Credit Facility to Accelerate Growth and Strategic Expansion

Aug 26, 2025, 7:00 AM EDT - 8 months ago

EDAP Announces Letter of Intent for 36 Million Euro Credit Facility to Accelerate Growth and Strategic Expansion

EDAP to Participate in the H.C. Wainwright 27th Annual Global Investment Conference

Aug 25, 2025, 7:00 AM EDT - 8 months ago

EDAP to Participate in the H.C. Wainwright 27th Annual Global Investment Conference

EDAP to Announce Second Quarter 2025 Financial Results on August 28, 2025

Aug 7, 2025, 7:00 AM EDT - 9 months ago

EDAP to Announce Second Quarter 2025 Financial Results on August 28, 2025

EDAP Announces Transition from Foreign Private Issuer to U.S. Domestic Filer Status

Jul 1, 2025, 7:00 AM EDT - 10 months ago

EDAP Announces Transition from Foreign Private Issuer to U.S. Domestic Filer Status

EDAP to Present at the Jefferies Global Healthcare Conference

May 27, 2025, 7:00 AM EDT - 11 months ago

EDAP to Present at the Jefferies Global Healthcare Conference

EDAP Reports First Quarter 2025 Financial Results

May 15, 2025, 7:00 AM EDT - 1 year ago

EDAP Reports First Quarter 2025 Financial Results

EDAP to Announce First Quarter 2025 Financial Results on May 15, 2025

May 1, 2025, 7:00 AM EDT - 1 year ago

EDAP to Announce First Quarter 2025 Financial Results on May 15, 2025

EDAP Announces Positive Results from the FARP Randomized Controlled Trial Presented at the American Urological Association (AUA) Annual Meeting

Apr 29, 2025, 7:00 AM EDT - 1 year ago

EDAP Announces Positive Results from the FARP Randomized Controlled Trial Presented at the American Urological Association (AUA) Annual Meeting

EDAP To Launch New Focal One® i Robotic HIFU system at the Upcoming 120th American Urological Association (AUA) Annual Meeting

Apr 24, 2025, 7:00 AM EDT - 1 year ago

EDAP To Launch New Focal One® i Robotic HIFU system at the Upcoming 120th American Urological Association (AUA) Annual Meeting

EDAP Announces Significant Presence of Focal One® at the Upcoming 120th American Urological Association (AUA) Annual Meeting

Apr 22, 2025, 7:00 AM EDT - 1 year ago

EDAP Announces Significant Presence of Focal One® at the Upcoming 120th American Urological Association (AUA) Annual Meeting

EDAP Reports Record HIFU Fourth Quarter and Full-Year 2024 Results

Mar 27, 2025, 7:10 AM EDT - 1 year ago

EDAP Reports Record HIFU Fourth Quarter and Full-Year 2024 Results

EDAP to Announce Fourth Quarter and Full Year 2024 Financial Results on March 27, 2025

Mar 6, 2025, 7:00 AM EST - 1 year ago

EDAP to Announce Fourth Quarter and Full Year 2024 Financial Results on March 27, 2025

EDAP Appoints Glen French to Board of Directors

Mar 3, 2025, 7:00 AM EST - 1 year ago

EDAP Appoints Glen French to Board of Directors

LUNG

Cortechs.ai and EDAP Announce World's First OnQ™ Prostate-Assisted Focal One® Robotic HIFU Procedure at UCSF Prostate Cancer Center

Feb 6, 2025, 8:00 AM EST - 1 year ago

Cortechs.ai and EDAP Announce World's First OnQ™ Prostate-Assisted Focal One® Robotic HIFU Procedure at UCSF Prostate Cancer Center

EDAP Announces Preliminary Record Fourth Quarter Focal One® System Sales and Record U.S. Procedures

Jan 13, 2025, 7:00 AM EST - 1 year ago

EDAP Announces Preliminary Record Fourth Quarter Focal One® System Sales and Record U.S. Procedures

EDAP Appoints Joshua H. Levine to Board of Directors

Jan 10, 2025, 7:00 AM EST - 1 year ago

EDAP Appoints Joshua H. Levine to Board of Directors

EDAP Announces First Pancreatic Cancer Patient Treated with Proprietary HIFU Technology

Jan 8, 2025, 7:00 AM EST - 1 year ago

EDAP Announces First Pancreatic Cancer Patient Treated with Proprietary HIFU Technology

Landmark HIFI Study Publication Demonstrates Positive Outcomes with Focal One® Robotic HIFU Versus Surgery in the Management of Prostate Cancer

Dec 4, 2024, 9:10 AM EST - 1 year ago

Landmark HIFI Study Publication Demonstrates Positive Outcomes with Focal One® Robotic HIFU Versus Surgery in the Management of Prostate Cancer

EDAP Announces Scientific Presentation at 2024 AAGL Global Congress Comparing Focal One HIFU Versus Surgery for the Treatment of Deep Infiltrating Endometriosis

Nov 19, 2024, 8:00 AM EST - 1 year ago

EDAP Announces Scientific Presentation at 2024 AAGL Global Congress Comparing Focal One HIFU Versus Surgery for the Treatment of Deep Infiltrating Endometriosis

EDAP to Announce Third Quarter 2024 Financial Results on November 7, 2024

Oct 24, 2024, 8:00 AM EDT - 1 year ago

EDAP to Announce Third Quarter 2024 Financial Results on November 7, 2024

EDAP and Avenda Health Launch World's First AI-Assisted Focal One® Robotic HIFU Procedures

Sep 19, 2024, 8:00 AM EDT - 1 year ago

EDAP and Avenda Health Launch World's First AI-Assisted Focal One® Robotic HIFU Procedures

EDAP to Participate in the H.C. Wainwright 26th Annual Global Investment Conference

Aug 29, 2024, 8:00 AM EDT - 1 year ago

EDAP to Participate in the H.C. Wainwright 26th Annual Global Investment Conference

EDAP Reports Second Quarter 2024 Financial Results

Aug 28, 2024, 7:00 AM EDT - 1 year ago

EDAP Reports Second Quarter 2024 Financial Results

EDAP to Announce Second Quarter 2024 Financial Results on August 28, 2024

Aug 7, 2024, 7:00 AM EDT - 1 year ago

EDAP to Announce Second Quarter 2024 Financial Results on August 28, 2024

EDAP Announces Interim Results from Phase 3 Study Evaluating Robotic HIFU for the Treatment of Deep Infiltrating Endometriosis

Jul 19, 2024, 4:15 PM EDT - 1 year ago

EDAP Announces Interim Results from Phase 3 Study Evaluating Robotic HIFU for the Treatment of Deep Infiltrating Endometriosis

EDAP Appoints New Executive Leaders to Strengthen Europe and Middle East Commercial Operations

Jun 3, 2024, 8:00 AM EDT - 2 years ago

EDAP Appoints New Executive Leaders to Strengthen Europe and Middle East Commercial Operations

EDAP Announces Positive Final Results from the HIFI Study Comparing Outcomes of Focal One® HIFU Versus Radical Prostatectomy During Plenary Session at the 119th American Urological Association (AUA) Annual Meeting

May 6, 2024, 8:00 AM EDT - 2 years ago

EDAP Announces Positive Final Results from the HIFI Study Comparing Outcomes of Focal One® HIFU Versus Radical Prostatectomy During Plenary Session at the 119th American Urological Association (AUA) Annual Meeting

EDAP to Announce First Quarter 2024 Financial Results on May 16, 2024

May 2, 2024, 8:00 AM EDT - 2 years ago

EDAP to Announce First Quarter 2024 Financial Results on May 16, 2024

EDAP Announces Final Results from HIFI Study Comparing Outcomes of Focal One® HIFU Versus Radical Prostatectomy to be Presented During Plenary Session at the Upcoming 119th American Urological Association (AUA) Annual Meeting

Apr 23, 2024, 8:00 AM EDT - 2 years ago

EDAP Announces Final Results from HIFI Study Comparing Outcomes of Focal One® HIFU Versus Radical Prostatectomy to be Presented During Plenary Session at the Upcoming 119th American Urological Association (AUA) Annual Meeting

EDAP to Announce Fourth Quarter and Full-Year 2023 Financial Results on March 27, 2024

Mar 13, 2024, 7:00 AM EDT - 2 years ago

EDAP to Announce Fourth Quarter and Full-Year 2023 Financial Results on March 27, 2024

EDAP to Present at the Oppenheimer 34th Annual Healthcare MedTech & Services Conference

Mar 6, 2024, 7:00 AM EST - 2 years ago

EDAP to Present at the Oppenheimer 34th Annual Healthcare MedTech & Services Conference

EDAP Announces FDA Breakthrough Device Designation for Focal One® in the Treatment of Deep Infiltrating Rectal Endometriosis

Mar 4, 2024, 7:00 AM EST - 2 years ago

EDAP Announces FDA Breakthrough Device Designation for Focal One® in the Treatment of Deep Infiltrating Rectal Endometriosis

EDAP Announces Record Preliminary Fourth Quarter and Full-Year 2023 Revenues

Feb 29, 2024, 7:00 AM EST - 2 years ago

EDAP Announces Record Preliminary Fourth Quarter and Full-Year 2023 Revenues

Georges8792
Georges8792 Apr. 24 at 7:45 AM
$EDAP https://www.linkedin.com/posts/joshua-darley-999507115_roboticsurgery-gynaecology-endometriosis-share-7453346687919656960-dqAB?utm_source=social_share_send&utm_medium=ios_app&rcm=ACoAADRx6v4B54eq7jmLG3UwhtnBprtqfVsygQg&utm_campaign=share_via
0 · Reply
Georges8792
Georges8792 Apr. 23 at 4:51 AM
$EDAP https://www.linkedin.com/posts/prakash-singh-30b07a338_the-future-of-prostate-cancer-treatment-is-share-7452528077110272000-RDnM?utm_source=social_share_send&utm_medium=ios_app&rcm=ACoAADRx6v4B54eq7jmLG3UwhtnBprtqfVsygQg&utm_campaign=share_via
0 · Reply
finedge
finedge Apr. 21 at 6:42 PM
$EDAP watch for enhanced entry opportunity Mid May..Short term play as Tatiff -Freight on Delivey has increased and company will have to absorb.
2 · Reply
Georges8792
Georges8792 Apr. 21 at 5:15 PM
$EDAP https://www.linkedin.com/posts/cancer-prostatecancer-urology-share-7452397483571474432-7OvJ?utm_source=social_share_send&utm_medium=ios_app&rcm=ACoAADRx6v4B54eq7jmLG3UwhtnBprtqfVsygQg&utm_campaign=share_via
0 · Reply
Georges8792
Georges8792 Apr. 21 at 7:39 AM
$EDAP https://www.linkedin.com/posts/gil-dubernard-md-phd-endometriosis-expert-surgeon-and-sonologist-196bab135_hifu-endometriosis-share-7452086340013338625-q1ze?utm_source=social_share_send&utm_medium=ios_app&rcm=ACoAADRx6v4B54eq7jmLG3UwhtnBprtqfVsygQg&utm_campaign=share_via
0 · Reply
Georges8792
Georges8792 Apr. 21 at 7:38 AM
$EDAP https://www.linkedin.com/posts/vincent-bailly-995824209_focal-one-first-treatment-sweden-ugcPost-7451957981723877377-UV-q?utm_source=social_share_send&utm_medium=ios_app&rcm=ACoAADRx6v4B54eq7jmLG3UwhtnBprtqfVsygQg&utm_campaign=share_via
0 · Reply
mikegrand
mikegrand Apr. 19 at 11:47 PM
$EDAP one thing I’ve looked over that was pretty big was the collaboration with IRCAD, I’ve never really looked into them because it wasn’t a hospital system but that’s pretty big that EDAP is the primary focal therapy machine in their facility. IRCAD is regarded as the number one minimally invasive training facility in the world and they train over 5000 doctors annually. This will vastly increase the amount of doctors that know Focal One and as of right now they only have a machine in Strasbourg but I expect them to expand to the other training facilities across the globe
0 · Reply
finedge
finedge Apr. 17 at 1:38 PM
$EDAP adjusting prediction date fluid markets
2 · Reply
finedge
finedge Apr. 17 at 1:38 PM
$EDAP
0 · Reply
Georges8792
Georges8792 Apr. 17 at 1:33 PM
$EDAP https://www.linkedin.com/posts/urooncologia-cirurgiaminimamentelnvasiva-ugcPost-7450612787254525952-BSWb?utm_source=social_share_send&utm_medium=ios_app&rcm=ACoAADRx6v4B54eq7jmLG3UwhtnBprtqfVsygQg&utm_campaign=share_via
0 · Reply
Georges8792
Georges8792 Apr. 17 at 10:29 AM
$EDAP https://www.linkedin.com/posts/you-are-invited-to-attend-this-virtual-event-share-7450637914243506177-v-A3?utm_source=social_share_send&utm_medium=ios_app&rcm=ACoAADRx6v4B54eq7jmLG3UwhtnBprtqfVsygQg&utm_campaign=share_via
0 · Reply
ritamargarita
ritamargarita Apr. 16 at 4:17 PM
$EDAP biotech movement, needs follow through
0 · Reply
mikegrand
mikegrand Apr. 13 at 2:03 AM
$EDAP unfortunately it seems we are heading into a 2020 style market and while that’s gonna be good on the side of accumulating shares (I’ll probably get my ownership up to 40k shares during this). It is going to be very hard on company cash reserves, it was actually pretty smart to get an EIB loan now looking at the market cause offerings are now gonna give barely anything. I hope the market upturns during the year but all signs do not show that
0 · Reply
Georges8792
Georges8792 Apr. 10 at 9:07 AM
$EDAP https://www.linkedin.com/posts/cancer-prostatecancer-urology-share-7448084026231386113-GePs?utm_source=social_share_send&utm_medium=ios_app&rcm=ACoAADRx6v4B54eq7jmLG3UwhtnBprtqfVsygQg&utm_campaign=share_via
0 · Reply
HypnoTrader
HypnoTrader Apr. 10 at 1:11 AM
$EDAP they filed an S-3, so they are probably going to raise capital in addition to what is already agreed with the warrants.
2 · Reply
finedge
finedge Apr. 9 at 11:52 PM
$EDAP highlight from tranche was warrants of 1.1 mil at .13 at a strike of 3.23. I’d love to have bought them warrants a lot less than the spread on an Option at 2.50. Dilution not good for the short term. Downtick contiuned to be pressure point
1 · Reply
acsalvo
acsalvo Apr. 8 at 3:21 PM
$EDAP a reread of the Q1 2025 might be useful in understanding the progress company has made this year
0 · Reply
OfficialStocktwitsUser
OfficialStocktwitsUser Apr. 8 at 4:37 AM
$EDAP RSI: 35.80, MACD: -0.1840 Vol: 0.26, MA20: 3.83, MA50: 4.17 🔴 SELL - Downtrend 👉 https://quantumstockalerts.com Disclaimer: I am not a financial advisor. This post reflects personal analysis and opinions only. Please do your own research before investing or trading.
0 · Reply
focafoca99
focafoca99 Apr. 3 at 8:29 PM
$EDAP is drawing the 12 million euro second tranche of its EIB facility and issued 1,116,244 warrants alongside it.
1 · Reply
finedge
finedge Apr. 2 at 5:00 PM
$EDAP for those in the money, it’s ok to sell off 1/3 and 1/3 at levels perosnally acceptable and jump back in the lower levels when it makes sense. Everyone’s situation is unique. Remember, we are just individual shareholders in for the long term and future valuation.
0 · Reply
finedge
finedge Apr. 2 at 4:53 PM
$EDAP appears the warrant offering is attractive to institutional investments and will continue to regress pricing from current levels. Temporarily. Watch for the shares coming into market. Update on proposed pricing. Will be a way to dollar cost average your Holdings if you plan on long term till consolidation.
0 · Reply
Georges8792
Georges8792 Apr. 2 at 4:04 PM
$EDAP https://www.linkedin.com/posts/jenny-robeson-3b0b024_excited-to-see-thiscongratulations-to-dr-ugcPost-7445500404764905472-HTK0?utm_source=social_share_send&utm_medium=ios_app&rcm=ACoAADRx6v4B54eq7jmLG3UwhtnBprtqfVsygQg&utm_campaign=share_via
0 · Reply